Hyman Muss

18PUBLICATIONS
76CO-AUTHORS
Predictive and prognostic markersBehavioural epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Data and information privacyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 10, 2026
p16INK4a and DNA methylation clocks in women treated with chemotherapy for early breast cancer.

|Mar 12, 2025
Feasibility of Measuring Context Specific Sedentary Behavior and Pulse Wave Velocity in Endometrial Cancer Survivors.

Lauren C Bates-Fraser, Jake C Diana, Aiden J Chauntry

|Jan 02, 2025
Adjuvant Dose-Dense Chemotherapy in Hormone Receptor-Positive Breast Cancer.

Otto Metzger Filho, Karla Ballman, Jordan Campbell

|Jun 24, 2024
Dose delay, dose reduction, and early treatment discontinuation in Black and White women receiving chemotherapy for nonmetastatic breast cancer.

Moriah Forster, Allison M Deal, Annie Page

|May 21, 2024
"They don't care to study it": Trust, race, and health care experiences among patient-caregiver dyads with multiple myeloma.

Shakira J Grant, Jiona A Mills, Joseph Telfair

|Nov 14, 2023
Falls prechemotherapy and toxicity-related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trial.

Jingran Ji, Marie Bae, Can-Lan Sun

Pageof 3

Frequent Collaborators

7 joint publications

Mina S Sedrak

5 joint publications

William P Tew

4 joint publications

Lisa Carey

4 joint publications

William Dale